These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10065930)

  • 1. Characterization of serotonergic mechanisms involved in the behavioural inhibition induced by 5-hydroxytryptophan in a modified light-dark test in mice.
    Artaiz I; Zazpe A; Del Río J
    Behav Pharmacol; 1998 Mar; 9(2):103-12. PubMed ID: 10065930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
    Stenfors C; Yu H; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of the 5-HT4 receptor.
    Costall B; Naylor RJ
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():11-8. PubMed ID: 8201242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    Sánchez C; Hyttel J
    Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test.
    Schreiber R; Melon C; De Vry J
    Psychopharmacology (Berl); 1998 Feb; 135(4):383-91. PubMed ID: 9539263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
    Costall B; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of pre- and post-synaptic 5-HT1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats.
    Ciccocioppo R; Panocka I; Polidori C; Dourish CT; Massi M
    Psychopharmacology (Berl); 1997 Nov; 134(1):55-63. PubMed ID: 9399367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test.
    Cheng CH; Costall B; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1994 Apr; 255(1-3):39-49. PubMed ID: 7913044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesis.
    Moret C; Briley M
    J Neural Transm (Vienna); 1997; 104(2-3):147-60. PubMed ID: 9203078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic modulation of nicotine-induced kinetic tremor in mice.
    Kunisawa N; Iha HA; Nomura Y; Onishi M; Matsubara N; Shimizu S; Ohno Y
    J Pharmacol Sci; 2017 Jun; 134(2):131-138. PubMed ID: 28647281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
    Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL; Hutson PH
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.
    Sánchez C
    Pharmacol Toxicol; 1995 Jul; 77(1):71-8. PubMed ID: 8532615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds. hsj@mfi.ku.dk.
    Jørgensen H; Knigge U; Kjaer A; Warberg J
    J Neuroendocrinol; 1999 Apr; 11(4):283-90. PubMed ID: 10223282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.